HEADER HYDROLASE 07-OCT-05 2D44 TITLE CRYSTAL STRUCTURE OF ARABINOFURANOSIDASE COMPLEXED WITH TITLE 2 ARABINOFURANOSYL-ALPHA-1,2-XYLOBIOSE CAVEAT 2D44 XYS C 1 HAS WRONG CHIRALITY AT ATOM C1 XYS C 2 HAS WRONG CAVEAT 2 2D44 CHIRALITY AT ATOM C1 XYS D 1 HAS WRONG CHIRALITY AT ATOM C1 CAVEAT 3 2D44 XYS D 2 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-L-ARABINOFURANOSIDASE B; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 19-499; COMPND 5 EC: 3.2.1.55; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ASPERGILLUS KAWACHII; SOURCE 3 ORGANISM_TAXID: 40384; SOURCE 4 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: GS115; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PPICZAC KEYWDS ARABINOFURANOSYL-ALPHA-1, 2-XYLOBIOSE COMPLEX, HYDROLASE, STRUCTURAL KEYWDS 2 GENOMICS EXPDTA X-RAY DIFFRACTION AUTHOR A.MIYANAGA,T.KOSEKI,Y.MIWA,H.MATSUZAWA,T.WAKAGI,H.SHOUN,S.FUSHINOBU REVDAT 6 10-NOV-21 2D44 1 SEQADV HETSYN REVDAT 5 29-JUL-20 2D44 1 CAVEAT COMPND REMARK SEQADV REVDAT 5 2 1 HETNAM LINK SITE ATOM REVDAT 4 13-JUL-11 2D44 1 VERSN REVDAT 3 24-FEB-09 2D44 1 VERSN REVDAT 2 24-OCT-06 2D44 1 JRNL REVDAT 1 19-SEP-06 2D44 0 JRNL AUTH A.MIYANAGA,T.KOSEKI,Y.MIWA,Y.MESE,S.NAKAMURA,A.KUNO, JRNL AUTH 2 J.HIRABAYASHI,H.MATSUZAWA,T.WAKAGI,H.SHOUN,S.FUSHINOBU JRNL TITL THE FAMILY 42 CARBOHYDRATE-BINDING MODULE OF FAMILY 54 JRNL TITL 2 ALPHA-L-ARABINOFURANOSIDASE SPECIFICALLY BINDS THE JRNL TITL 3 ARABINOFURANOSE SIDE CHAIN OF HEMICELLULOSE JRNL REF BIOCHEM.J. V. 399 503 2006 JRNL REFN ISSN 0264-6021 JRNL PMID 16846393 JRNL DOI 10.1042/BJ20060567 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1741504.070 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 21533 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1079 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 66.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2686 REMARK 3 BIN R VALUE (WORKING SET) : 0.2700 REMARK 3 BIN FREE R VALUE : 0.3270 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 132 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.028 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3575 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 84 REMARK 3 SOLVENT ATOMS : 118 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.74000 REMARK 3 B22 (A**2) : 23.41000 REMARK 3 B33 (A**2) : -14.67000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM SIGMAA (A) : 0.28 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.36 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.780 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.830 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.410 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.670 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.460 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 32.18 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : NAG2.PAR REMARK 3 PARAMETER FILE 3 : WATER.PARAM REMARK 3 PARAMETER FILE 4 : CIS_PEPTIDE.PARAM REMARK 3 PARAMETER FILE 5 : AXX.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NAG2.TOP REMARK 3 TOPOLOGY FILE 5 : AXX.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2D44 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 13-OCT-05. REMARK 100 THE DEPOSITION ID IS D_1000024963. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-5A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25910 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 83.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 67.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.76 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG6000, 0.1M MES-NAOH, PH 6.0, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.76500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 71.97300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 49.37400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 71.97300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.76500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 49.37400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O4 NAG B 1 O5 NAG B 2 2.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 36 131.37 -175.45 REMARK 500 GLU A 196 93.18 -166.36 REMARK 500 TRP A 206 -100.77 -122.71 REMARK 500 ALA A 221 122.57 82.96 REMARK 500 ASN A 223 131.85 170.69 REMARK 500 LYS A 286 151.02 -48.91 REMARK 500 PRO A 342 -70.55 -37.76 REMARK 500 SER A 343 166.74 76.47 REMARK 500 THR A 360 -3.25 -55.22 REMARK 500 ALA A 365 -158.28 -135.95 REMARK 500 ASP A 368 -139.86 73.24 REMARK 500 CYS A 401 -158.89 -99.80 REMARK 500 THR A 409 71.00 -118.12 REMARK 500 PRO A 457 -13.95 -47.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1WD3 RELATED DB: PDB REMARK 900 RELATED ID: 1WD4 RELATED DB: PDB REMARK 900 RELATED ID: 2D43 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH ARABINOTRIOSE DBREF 2D44 A 19 499 GB 21280333 BAB96816 19 499 SEQADV 2D44 MET A 18 GB 21280333 INITIATING METHIONINE SEQADV 2D44 ALA A 221 GB 21280333 GLU 221 ENGINEERED MUTATION SEQRES 1 A 482 MET GLY PRO CYS ASP ILE TYR GLU ALA GLY ASP THR PRO SEQRES 2 A 482 CYS VAL ALA ALA HIS SER THR THR ARG ALA LEU TYR SER SEQRES 3 A 482 SER PHE SER GLY ALA LEU TYR GLN LEU GLN ARG GLY SER SEQRES 4 A 482 ASP ASP THR THR THR THR ILE SER PRO LEU THR ALA GLY SEQRES 5 A 482 GLY ILE ALA ASP ALA SER ALA GLN ASP THR PHE CYS ALA SEQRES 6 A 482 ASN THR THR CYS LEU ILE THR ILE ILE TYR ASP GLN SER SEQRES 7 A 482 GLY ASN GLY ASN HIS LEU THR GLN ALA PRO PRO GLY GLY SEQRES 8 A 482 PHE ASP GLY PRO ASP THR ASP GLY TYR ASP ASN LEU ALA SEQRES 9 A 482 SER ALA ILE GLY ALA PRO VAL THR LEU ASN GLY GLN LYS SEQRES 10 A 482 ALA TYR GLY VAL PHE MET SER PRO GLY THR GLY TYR ARG SEQRES 11 A 482 ASN ASN GLU ALA THR GLY THR ALA THR GLY ASP GLU ALA SEQRES 12 A 482 GLU GLY MET TYR ALA VAL LEU ASP GLY THR HIS TYR ASN SEQRES 13 A 482 ASP ALA CYS CYS PHE ASP TYR GLY ASN ALA GLU THR SER SEQRES 14 A 482 SER THR ASP THR GLY ALA GLY HIS MET GLU ALA ILE TYR SEQRES 15 A 482 LEU GLY ASN SER THR THR TRP GLY TYR GLY ALA GLY ASP SEQRES 16 A 482 GLY PRO TRP ILE MET VAL ASP MET ALA ASN ASN LEU PHE SEQRES 17 A 482 SER GLY ALA ASP GLU GLY TYR ASN SER GLY ASP PRO SER SEQRES 18 A 482 ILE SER TYR ARG PHE VAL THR ALA ALA VAL LYS GLY GLY SEQRES 19 A 482 ALA ASP LYS TRP ALA ILE ARG GLY ALA ASN ALA ALA SER SEQRES 20 A 482 GLY SER LEU SER THR TYR TYR SER GLY ALA ARG PRO ASP SEQRES 21 A 482 TYR SER GLY TYR ASN PRO MET SER LYS GLU GLY ALA ILE SEQRES 22 A 482 ILE LEU GLY ILE GLY GLY ASP ASN SER ASN GLY ALA GLN SEQRES 23 A 482 GLY THR PHE TYR GLU GLY VAL MET THR SER GLY TYR PRO SEQRES 24 A 482 SER ASP ASP THR GLU ASN SER VAL GLN GLU ASN ILE VAL SEQRES 25 A 482 ALA ALA LYS TYR VAL VAL GLY SER LEU VAL SER GLY PRO SEQRES 26 A 482 SER PHE THR SER GLY GLU VAL VAL SER LEU ARG VAL THR SEQRES 27 A 482 THR PRO GLY TYR THR THR ARG TYR ILE ALA HIS THR ASP SEQRES 28 A 482 THR THR VAL ASN THR GLN VAL VAL ASP ASP ASP SER SER SEQRES 29 A 482 THR THR LEU LYS GLU GLU ALA SER TRP THR VAL VAL THR SEQRES 30 A 482 GLY LEU ALA ASN SER GLN CYS PHE SER PHE GLU SER VAL SEQRES 31 A 482 ASP THR PRO GLY SER TYR ILE ARG HIS TYR ASN PHE GLU SEQRES 32 A 482 LEU LEU LEU ASN ALA ASN ASP GLY THR LYS GLN PHE HIS SEQRES 33 A 482 GLU ASP ALA THR PHE CYS PRO GLN ALA ALA LEU ASN GLY SEQRES 34 A 482 GLU GLY THR SER LEU ARG SER TRP SER TYR PRO THR ARG SEQRES 35 A 482 TYR PHE ARG HIS TYR GLU ASN VAL LEU TYR ALA ALA SER SEQRES 36 A 482 ASN GLY GLY VAL GLN THR PHE ASP SER LYS THR SER PHE SEQRES 37 A 482 ASN ASN ASP VAL SER PHE GLU ILE GLU THR ALA PHE ALA SEQRES 38 A 482 SER MODRES 2D44 ASN A 202 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET XYS C 1 10 HET XYS C 2 9 HET AHR C 3 9 HET XYS D 1 10 HET XYS D 2 9 HET AHR D 3 9 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM XYS ALPHA-D-XYLOPYRANOSE HETNAM AHR ALPHA-L-ARABINOFURANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN XYS ALPHA-D-XYLOSE; D-XYLOSE; XYLOSE; XYLOPYRANOSE HETSYN AHR ALPHA-L-ARABINOSE; L-ARABINOSE; ARABINOSE FORMUL 2 NAG 2(C8 H15 N O6) FORMUL 3 XYS 4(C5 H10 O5) FORMUL 3 AHR 2(C5 H10 O5) FORMUL 5 HOH *118(H2 O) HELIX 1 1 GLY A 19 GLY A 27 1 9 HELIX 2 2 ASP A 73 CYS A 81 1 9 HELIX 3 3 ASP A 113 TYR A 117 5 5 HELIX 4 4 SER A 317 LYS A 332 1 16 HELIX 5 5 SER A 381 ALA A 388 1 8 HELIX 6 6 THR A 429 ALA A 436 1 8 HELIX 7 7 GLN A 477 SER A 481 5 5 HELIX 8 8 SER A 484 VAL A 489 1 6 SHEET 1 A 6 CYS A 31 SER A 36 0 SHEET 2 A 6 GLY A 304 SER A 313 -1 O GLY A 309 N HIS A 35 SHEET 3 A 6 GLU A 161 LEU A 167 -1 N GLY A 162 O THR A 312 SHEET 4 A 6 VAL A 244 GLY A 251 -1 O VAL A 244 N LEU A 167 SHEET 5 A 6 LYS A 254 ASN A 261 -1 O LYS A 254 N GLY A 251 SHEET 6 A 6 SER A 264 GLY A 273 -1 O SER A 268 N GLY A 259 SHEET 1 B 5 CYS A 31 SER A 36 0 SHEET 2 B 5 GLY A 304 SER A 313 -1 O GLY A 309 N HIS A 35 SHEET 3 B 5 GLN A 133 MET A 140 -1 N VAL A 138 O PHE A 306 SHEET 4 B 5 ALA A 126 LEU A 130 -1 N VAL A 128 O ALA A 135 SHEET 5 B 5 TYR A 333 VAL A 335 -1 O VAL A 334 N THR A 129 SHEET 1 C 4 THR A 60 ILE A 63 0 SHEET 2 C 4 TYR A 50 ARG A 54 -1 N LEU A 52 O THR A 61 SHEET 3 C 4 CYS A 86 ILE A 91 -1 O ILE A 90 N GLN A 51 SHEET 4 C 4 ALA A 121 SER A 122 -1 O ALA A 121 N ILE A 88 SHEET 1 D10 THR A 60 ILE A 63 0 SHEET 2 D10 TYR A 50 ARG A 54 -1 N LEU A 52 O THR A 61 SHEET 3 D10 CYS A 86 ILE A 91 -1 O ILE A 90 N GLN A 51 SHEET 4 D10 LEU A 101 GLN A 103 -1 O LEU A 101 N ILE A 91 SHEET 5 D10 TYR A 146 ASN A 148 -1 O ARG A 147 N THR A 102 SHEET 6 D10 ALA A 289 LEU A 292 -1 O ILE A 290 N ASN A 148 SHEET 7 D10 ASP A 179 ALA A 183 -1 N ALA A 183 O ALA A 289 SHEET 8 D10 GLU A 196 GLY A 201 -1 O ILE A 198 N TYR A 180 SHEET 9 D10 TRP A 215 ASP A 219 -1 O ASP A 219 N ALA A 197 SHEET 10 D10 LEU A 224 PHE A 225 -1 O PHE A 225 N VAL A 218 SHEET 1 E 4 PHE A 402 SER A 406 0 SHEET 2 E 4 TRP A 390 THR A 394 -1 N THR A 391 O GLU A 405 SHEET 3 E 4 VAL A 349 VAL A 354 -1 N VAL A 350 O TRP A 390 SHEET 4 E 4 PHE A 491 THR A 495 -1 O GLU A 494 N SER A 351 SHEET 1 F 2 ARG A 362 THR A 367 0 SHEET 2 F 2 THR A 370 VAL A 375 -1 O ASN A 372 N ALA A 365 SHEET 1 G 2 SER A 412 TYR A 417 0 SHEET 2 G 2 GLU A 420 ALA A 425 -1 O LEU A 422 N ARG A 415 SHEET 1 H 2 PHE A 438 ALA A 442 0 SHEET 2 H 2 THR A 449 SER A 453 -1 O ARG A 452 N CYS A 439 SHEET 1 I 2 ARG A 459 TYR A 464 0 SHEET 2 I 2 VAL A 467 SER A 472 -1 O TYR A 469 N ARG A 462 SSBOND 1 CYS A 21 CYS A 31 1555 1555 2.05 SSBOND 2 CYS A 81 CYS A 86 1555 1555 2.03 SSBOND 3 CYS A 176 CYS A 177 1555 1555 2.03 SSBOND 4 CYS A 401 CYS A 439 1555 1555 2.04 LINK ND2 ASN A 202 C1 NAG B 1 1555 1555 1.69 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.47 LINK O4 XYS C 1 C1 XYS C 2 1555 1555 1.40 LINK O2 XYS C 2 C1 AHR C 3 1555 1555 1.46 LINK O4 XYS D 1 C1 XYS D 2 1555 1555 1.41 LINK O2 XYS D 2 C1 AHR D 3 1555 1555 1.46 CISPEP 1 CYS A 176 CYS A 177 0 -0.42 CISPEP 2 GLY A 213 PRO A 214 0 -0.08 CISPEP 3 ASN A 282 PRO A 283 0 -0.01 CRYST1 39.530 98.748 143.946 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025297 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010127 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006947 0.00000